Biotech | February 18, 2022
Sandoz launches generic lenalidomide in 19 countries across Europe
Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines
Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines
The Vasostrict brand market had U.S. sales of approximately US $ 878.5 million MAT for the most recent twelve months ending in December 2021 according to IQVIA Health
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
A total of 12 generic medicines have been included in the list
Ibuprofen and Famotidine tablets (Duexise) had estimated annual sales of US $ 765 million in the US as if July 21
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
Floods had forced the plans in Mahad to shut down
Subscribe To Our Newsletter & Stay Updated
